GHRP-2 yog ib qho hluavtaws hexapeptide uas ua raws li lub zog agonist ntawm kev loj hlob hormone secretagogue receptor (GHSR-1a), tib tsev neeg receptor koom nrog endogenous ghrelin. Hauv cov qauv pituitary thiab hypothalamic, qhov sib xyaw ua rau muaj kev loj hlob sai ntawm cov tshuaj hormones (GH) tso tawm, feem ntau nrog cov yam ntxwv ntawm cov mem tes profile uas ua rau nws muaj txiaj ntsig rau kev kawm GH physiology, IGF-1 kev cai, thiab downstream anabolic signaling.
Ua tsaug rau nws qhov muaj zog thiab rov tsim dua GH-tso tawm profile, cov khoom siv dav siv hauv GH stimulation paradigms, kev tshawb fawb sib piv piv rau GHRH analogs (xws li Sermorelin, Tesamorelin), thiab cov qauv uas tshawb xyuas cov pob txha, pob txha, thiab kho metabolic. Cov khoom no tau sau nruj me ntsis rau kev tshawb fawb siv nkaus xwb thiab tsis yog rau kev kuaj mob, kev kho mob, lossis kev tswj tus kheej -.
COA
|
|
||
|
Khoom npe |
CAS Nr |
Batch Number |
|
GHRP-2 |
158861-67-7 |
MB2508261715 |
|
Hnub tim tsim khoom |
Hnub Soj Ntsuam |
Hnub Kawg |
|
2025-08-26 |
2025-08-27 |
2027-08-25 |
|
Qauv Qty Base |
Ntim |
Txoj Kev Xeem |
|
7 15 gs |
5GS / lub raj mis |
HPLC |
|
Yam khoom |
Txuj |
Cov txiaj ntsig |
|
Purity |
Ntau dua lossis sib npaug li 98% |
98.57% |
|
Peptide Assay |
Ntau dua lossis sib npaug li 80% |
88.91% |
|
Loj Spectrum |
817.97 |
817.97 |
|
Solubility |
Soluble hauv dej |
Ua raws |
|
Clarity thiab xim ntawm kev daws |
Ntshiab thiab tsis muaj xim |
Ua raws |
|
ntsev |
<5.0% |
1.35% |
|
Dej |
Tsawg dua lossis sib npaug li 7.0% |
2.40% |
|
Cia |
Khaws rau hauv qhov chaw tsaus thiab txias qhuav (-20 txog 8 degree) |
|
|
Xaus |
Cov batch ua raws li IN-HOUSE tus qauv |
|
|
|
||
Specifications (rau kev tshawb fawb siv nkaus xwb)
|
Daim ntawv |
Qauv Order |
Specification |
|
Cov hmoov nyoos |
1 g |
Purity yog NLT 99% |
|
Vials |
10 vials |
3ml / 5ml / 7ml / 15ml vials thiab lwm yam. |
Phau ntawv Snapshot
nyob rau hauv circulating GH nyob rau hauv feeb ntawm raug, ua raws li los ntawm kev kwv yees rov qab mus rau lub hauv paus pib dua 2-3 teev. Qhov luv luv, siab -amplitude GH mem tes ua rau nws yog ib qho cuab yeej siv tau rau kev ua qauv somatotroph teb, IGF-1 kev cai, thiab downstream anabolic cim xws li collagen synthesis thiab protein turnover.
Hauv cov qauv hypothalamic-pituitary, qhov sib xyaw ua ke xaiv GHSR-1a, ua rau cov kws tshawb fawb sib txawv PLC/Ca²⁺- txuas cov teeb liab los ntawm cAMP- tsav GHRH txoj hauv kev. Cov kev tshawb fawb tsiaj kuj qhia txog cov kev hloov pauv hauv kev noj zaub mov, kev tuav cov piam thaj, thiab cov pob txha hloov kho, txhawb nws txoj kev siv hauv kev tshawb fawb metabolic thiab rov tsim dua tshiab. Cov yam ntxwv no piav qhia vim li cas cov chaw kuaj mob feem ntau siv cov khoom siv hauv GH stimulation tests, kev sib xyaw ua ke nrog GHRH analogs, thiab kev tshawb fawb ntawm endocrine reserves.
Kev Tshawb Fawb Txog Kev Tshawb Fawb
Sermorelin vs Tesamorelin vs GHRP
Targets GHRH receptors nyob rau hauv lub anterior pituitary. Ua kom lub cAMP/PKA teeb liab txoj kev. Txhawb nqa pulsatile GH secretion. Mimics natural GH rhythms. Siv hauv kev tshawb fawb, GH deficiency qauv, thiab tiv thaiv- kev tshawb fawb kev laus. Functional core fragment ntawm endogenous GHRH. Hais txog physiological raug.
Kuj khi rau GHRH receptors, tab sis nrog txhim khu kev ruaj ntseg. Qhib tib txoj kev cAMP/PKA. Txhim kho IGF- 1 qib thiab txhim kho lipid metabolism. Pom zoo rau HIV-txog lipodystrophy hauv qee thaj tsam. Haum rau kev siv tshuaj kho mob. Ntev ib nrab -lub neej thiab ntau dua receptor affinity dua. Sermorelin.Often siv nyob rau hauv kho thiab translational kev tshawb fawb.
Ua kom lub PLC一 Ca²+ signaling pathway. Stimulates GH secretion ntawm ib tug txawv mechanism. Txhawb cov pob txha turnover thiab pob txha mos regeneration. Feem ntau siv hauv kev tshawb fawb txog metabolic thiab cov ntaub so ntswg kho .Tuaj yeem ua ke nrog Sermorelin rau kev sib koom ua ke ntawm kev ywj pheej ntawm GHRH txoj hauv kev.
FAQ
Q: Kev siv GHRP-2 yog dab tsi?
A: GHRP-2 yog ib qho kev loj hlob hormone-tso peptide uas txhawb nqa pituitary GH secretion. Kev tshawb fawb feem ntau tshuaj xyuas nws cov teebmeem ntawm kev noj qab haus huv kev tswj hwm, metabolism, thiab GH axis kev ua haujlwm.
Q: Puas yog GHRP-2 zoo ib yam li Sermorelin?
A: Tsis yog. Sermorelin yog ib feem ntawm GHRH, whereas GHRP-2 yog ghrelin-mimetic ua yeeb yam ntawm cov receptors sib txawv. Ob leeg nce GH qib tab sis los ntawm cov txheej txheem sib txawv.
Q: Puas yog GHRP-2 nce qhov siab?
A: There is no evidence that GHRP-2 increases adult height because the growth plates are already closed. Data on height effects in children are limited and inconclusive.
Q: Puas yog GHRP nce testosterone?
A: Cov kev tshawb fawb tam sim no qhia tias GHRPs feem ntau nce GH thiab tsis ncaj qha txhawb kev tsim khoom ntawm testosterone. Txhua yam kev hloov hormonal yuav ua tsis ncaj thiab me me.
Q: Dab tsi yog qhov zoo tshaj peptide los tsim cov leeg?
A: Tsis muaj ib qho "peptide zoo tshaj" hauv cov ntaub ntawv tshawb fawb. Cov tshuaj xws li IGF-1 analogs, GHRPs, thiab GHRH analogs qhia qhov sib txawv, tab sis kev nyab xeeb mus sij hawm ntev thiab kev ua tau zoo tseem tsis paub meej.
Cim npe nrov: Tuam Tshoj ghrp peptide manufacturers, lwm tus neeg, Hoobkas
